Business News›Mutual Funds›ICICI Prudential Mutual Fund › ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
ICICI Prudential Pharma Healthcare and Diagnostics...
(Scheme Rating)
NAV as of Jan 27, 2025
39.23-2.46%
- Growth - Direct
(Earn upto 0.83% Extra Returns with Direct Plan)
Fund Category:
Equity: Sectoral-Pharma
Expense Ratio:
1.08%(0.71% Category
average)Fund Size:
Rs. 5,320.29 Cr(16.98% of Investment in Category)
- ADD TO PORTFOLIO
Loading...
ADD TO PORTFOLIO
ICICI Prudential Pharma Healthcare and Diagnostics (P.H....
(Scheme Rating)
NAV as of Jan 27, 2025
39.23-2.46%
Expense Ratio:
1.08%
Fund Size:
Rs. 5,320.29 Cr
Fund Category:
Equity: Sectoral-Pharma
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth Fund Key Highlights
1. Current NAV: The Current Net Asset Value of the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan as of Jan 27, 2025 is Rs 39.23 for Growth option of its Direct plan.
2. Returns: Its trailing returns over different time periods are: 61.89% (1yr), 23.7% (3yr), 32.33% (5yr) and 24.87% (since launch). Whereas, Category returns for the same time duration are: 54.646462731470585% (1yr), 19.32998732373461% (3yr) and 27.74541653265445% (5yr).
3. Fund Size: The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan currently holds Assets under Management worth of Rs 4987.487 crore as on Sep 30, 2024.
4. Expense ratio: The expense ratio of the fund is 1.06% for Direct plan as on Sep 30, 2024.
5. Exit Load: ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan shall attract an Exit Load, "Exit load of 1% if redeemed within 15 days."
6. Minimum Investment: Minimum investment required is Rs 5000 and minimum additional investment is Rs 1000. Minimum SIP investment is Rs 100.
1. Current NAV: The Current Net Asset Value of the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan as of Jan 27, 2025 is Rs 39.23 for Growth option of its Direct plan.
2. Returns: Its trailing returns over different time periods are: 61.89% (1yr), 23.7% (3yr), 32.33% (5yr) and 24.87% (since launch). Whereas, Category returns for the same time duration are: 54.646462731470585% (1yr), 19.32998732373461% (3yr) and 27.74541653265445% (5yr).
3. Fund Size: The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan currently holds Assets under Management worth of Rs 4987.487 crore as on Sep 30, 2024.
4. Expense ratio: The expense ratio of the fund is 1.06% for Direct plan as on Sep 30, 2024.
5. Exit Load: ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan shall attract an Exit Load, "Exit load of 1% if redeemed within 15 days."
6. Minimum Investment: Minimum investment required is Rs 5000 and minimum additional investment is Rs 1000. Minimum SIP investment is Rs 100.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth Returns
Trailing Returns
Rolling Returns
Discrete Period
SIP Returns
1M 3M 6M 1Y 3Y 5Y Annualized Returns -6.86 -2.99 4.17 29.97 24.57 28.60 Category Avg -7.78 -4.62 1.08 22.56 19.37 23.84 Rank within Category 5 5 5 2 1 1 No. of funds within Category 23 21 20 17 12 7 - Loading...
- Loading...
Return Comparison
- This Fund
- BenchmarkS&P BSE Sensex
Choose from Benchmarks
- Nifty 50
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth Fund Details
Investment Objective - The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
| Fund House | ICICI Prudential Mutual Fund |
| Launch Date | Jul 13, 2018 |
| Benchmark | |
| Return Since Launch | 23.21% |
| Riskometer | Very High |
| Type | Open-ended |
| Risk Grade | Low |
| Return Grade | High |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth Investment Details
| Minimum Investment (Rs.) | 5,000.00 |
| Minimum Additional Investment (Rs.) | 1,000.00 |
| Minimum SIP Investment (Rs.) | 100.00 |
| Minimum Withdrawal (Rs.) | 1.00 |
| Exit Load Exit load of 1% if redeemed within 15 days. | |
Portfolio Allocation
Asset Allocation
Loading...
Asset Allocation History
Loading...
EquityDebtCash
Sector Allocation
Loading...
Market Cap Allocation
Loading...
Concentration & Valuation Analysis
| DEC 2024 | NOV 2024 | OCT 2024 | SEP 2024 | AUG 2024 | JUL 2024 | |
|---|---|---|---|---|---|---|
| Number of Holdings | 41 | 44 | 43 | 42 | 40 | 40 |
| Top 5 Company Holdings | 42.65% | 39.61% | 40.61% | 40.87% | 38.41% | 39.01% |
| Top 10 Company Holdings | 61.21% | 56.48% | 56.64% | 56.76% | 56.55% | 58.64% |
| Company with Highest Exposure | Sun Pharmaceutical Industries (13.83%) | Sun Pharmaceutical Industries (13.77%) | Sun Pharmaceutical Industries (14.35%) | Sun Pharmaceutical Industries (15.45%) | Sun Pharmaceutical Industries (15.16%) | Sun Pharmaceutical Industries (15.28%) |
| Number of Sectors | 4 | 4 | 4 | 5 | 4 | 4 |
| Top 3 Sector Holdings | 97.16% | 96.15% | 96.98% | 93.37% | 94.8% | 96.43% |
| Top 5 Sector Holdings | 98.07% | 97.27% | 97.87% | 95.71% | 95.65% | 97.52% |
| Sector with Highest Exposure | Healthcare (93.34%) | Healthcare (91.13%) | Healthcare (94.27%) | Healthcare (90.21%) | Healthcare (91.86%) | Healthcare (92.13%) |
Top Stock Holdings
Sector Holdings in MF
Company Sector Assest(%) P/E EPS-TTM(₹) RETURN 1 YR(%) Sun Pharmaceutical Industries Healthcare 15.45 37.01 46.07 30.59 Dr. Reddy's Laboratories Healthcare 9.63 18.31 64.37 2.27 Cipla Healthcare 6.52 25.02 55.41 1.93 Lupin Healthcare 4.64 35.19 57.57 42.98 Gland Pharma Healthcare 4.63 - - - Aurobindo Pharma Healthcare 4.26 18.70 61.67 2.21 Apollo Hospitals Enterprise Healthcare 3.92 81.44 82.28 8.54 Divi's Laboratories Healthcare 2.86 79.79 69.16 55.82 Healthcare Global Enterprises Healthcare 2.55 120.78 4.09 40.27 Medplus Health Services Healthcare 2.3 - - -
Peer Comparison
Cumulative Returns
SIP returns
Discrete Returns
Quant Measures
Asset Allocation
Scheme Name NAV(Rs./Unit) Scheme Rating AUM(Rs. Cr) 1M 1Y 3Y 5Y ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth 39.23 5,320.29 -6.86 29.97 24.57 28.60 ITI Pharma and Healthcare Fund Direct - Growth 16.80 230.79 -8.57 25.66 20.48 - SBI Healthcare Opportunities Fund Direct Plan-Growth 460.63 3,628.03 -6.25 28.12 24.42 27.77 Tata India Pharma & Healthcare Fund Direct-Growth 33.21 1,287.45 -8.06 23.81 21.91 26.02 UTI Healthcare Fund Direct-Growth 296.45 1,235.91 -9.21 25.64 20.70 25.47
Risk Ratios
Ratios are calculated using the calendar month returns for the last 3 years
Standard Deviation
Standard Deviation
Standard deviation is the deviation of the fund's return around mean.
Low Volatality
14.95VS15.16Fund Vs Category Avg
Beta
Beta
Beta shows the portfolio risk in relation to the market. A beta of less than 1 means that the fund returns are less volatile compared to the broader market. A beta of more than 1 means that the fund returns are more volatile than the broader markets. A beta equal to 1 means that fund's volatility is in line with the broader market.
Low Volatality
0.91VS0.92Fund Vs Category Avg
Sharpe Ratio
Sharpe Ratio
Sharpe ratio is a risk adjusted performance measure. A fund with a higher Sharpe ratio is considered better than a fund with a lower Sharpe ratio.
Better risk-adjusted returns
1.19VS0.94Fund Vs Category Avg
Treynor's Ratio
Treynor's Ratio
Treynor is a risk adjusted performance measure. A fund with a higher Treynor ratio is considered better than a fund with a lower Treynor ratio.
Better risk-adjusted returns
19.66VS15.56Fund Vs Category Avg
Jensen's Alpha
Jensen's Alpha
Alpha shows the ability of the fund manager to outperform the market. A higher Alpha is preferred.
Better risk-adjusted returns
4.86VS1.14Fund Vs Category Avg
Mean Return
Mean Return
Average return generated by the fund during a specified period.
Better average monthly returns
23.82VS20.22Fund Vs Category Avg
Risk Ratio Chart
Loading...
- Risk Ratio
- Category Average
Size of Bubbles represents the Fund Size
ICICI Prudential Mutual Fund News
Fund Manager
- D.K.Dharmesh KakkadSince May 20209 schemes
Mr. kakkad is B.com., CA & CFA. He is associated with ICICI Prudential Asset Management Company Limited from June 2010. Prior to working in Dealing function, he was working in the Operations Department of ICICI Prudential AMC.
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y ICICI Prudential Value Discovery Direct-Growth Value Oriented 466.55 48,307.68 14.70 ICICI Prudential India Equity FOF Direct - Growth Flexi Cap 29.44 152.78 17.49 ICICI Prudential Income Optimizer Fund (FOF) Direct- Growth Conservative Hybrid 64.65 268.83 12.34 ICICI Prudential Asset Allocator Fund (FOF) Direct - Growth Multi Asset Allocation 123.03 23,679.54 12.92 ICICI Prudential Equity Savings Fund Direct-Growth Equity Savings 23.10 12,554.90 8.38 ICICI Prudential Passive Strategy Fund (FOF) Direct - Growth Flexi Cap 154.08 175.22 11.11 ICICI Prudential Passive Multi-Asset FoF Direct - Growth Multi Asset Allocation 13.94 Unrated 1,094.57 12.52 ICICI Prudential Global Advantage Fund (FOF) Direct - Growth International 16.47 Unrated 322.85 23.76 ICICI Prudential Thematic Advantage Fund (FOF)Direct- Growth Thematic 218.45 Unrated 2,198.75 18.91
More ICICI Prudential Mutual Fund
| Scheme Name | Rating | Asset Size(Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| ICICI Prudential Bluechip Fund Direct-Growth | 63,264.30 | -3.25 | -5.72 | -4.47 | 12.45 | 16.45 | |
| ICICI Prudential Balanced Advantage Direct-Growth | 60,434.09 | -1.32 | -1.79 | -0.18 | 11.10 | 12.45 | |
| ICICI Prudential Multi Asset Fund Direct-Growth | 51,027.46 | 0.60 | -1.50 | 1.34 | 17.00 | 19.30 | |
| ICICI Prudential Liquid Fund Direct Plan-Growth | 49,652.96 | 0.62 | 1.75 | 3.56 | 7.43 | 6.53 | |
| ICICI Prudential Value Discovery Direct-Growth | 48,307.68 | -2.09 | -5.01 | -3.34 | 15.51 | 21.24 | |
| ICICI Prudential Equity & Debt Fund Direct-Growth | 39,769.96 | -1.73 | -4.45 | -2.72 | 13.75 | 18.22 | |
| ICICI Prudential Corporate Bond Fund Direct Plan -Growth | 29,117.59 | 0.60 | 1.75 | 3.96 | 8.28 | 7.13 | |
| ICICI Prudential Money Market Direct-Growth | 25,286.22 | 0.62 | 1.78 | 3.66 | 7.77 | 6.78 | |
| ICICI Prudential India Opportunities Fund Direct - Growth | 24,552.50 | -3.08 | -5.07 | -2.44 | 18.29 | 24.88 | |
| ICICI Prudential Equity Arbitrage Direct-Growth | 24,369.11 | 0.71 | 1.96 | 3.80 | 8.14 | 6.99 |
Mutual Fund Tools
Top AMCs
- SBI Mutual Fund
- ICICI Prudential Mutual Fund
- HDFC Mutual Fund
- Nippon India Mutual Fund
- Kotak Mahindra Mutual Fund
- Aditya Birla Sun Life Mutual Fund
- UTI Mutual Fund
- Axis Mutual Fund
- Mirae Asset Mutual Fund
- DSP Mutual Fund
- Tata Mutual Fund
- Bandhan Mutual Fund
- Edelweiss Mutual Fund
- HSBC Mutual Fund
- Franklin Templeton Mutual Fund
About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
1. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan is Open-ended Sectoral-Pharma Equity scheme which belongs to ICICI Prudential Mutual Fund House.
2. The fund was launched on Jul 13, 2018.
Investment objective & Benchmark
1. The investment objective of the fund is that " The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. "
2. It is benchmarked against null.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 95.72087562% in equities, 0.0% in debts and 4.27912438% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 56.75999999999999% of the assets, the top 3 sectors constitute around 93.36999999999999% of the assets.
3. The fund largely follows a Blend oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.
1. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan is Open-ended Sectoral-Pharma Equity scheme which belongs to ICICI Prudential Mutual Fund House.
2. The fund was launched on Jul 13, 2018.
Investment objective & Benchmark
1. The investment objective of the fund is that " The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. "
2. It is benchmarked against null.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 95.72087562% in equities, 0.0% in debts and 4.27912438% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 56.75999999999999% of the assets, the top 3 sectors constitute around 93.36999999999999% of the assets.
3. The fund largely follows a Blend oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.
This Might Catch Your Interest
FAQs about ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
- Is it safe to invest in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan?As per SEBI’s latest guidelines to calculate risk grades, investment in the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan comes under Very High risk category.
- What is the category of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan?ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan belongs to the Equity : Sectoral-Pharma category of funds.
- How Long should I Invest in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan?The suggested investment horizon of investing into ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan is >3 years. The suggested investment horizon is the minimum time required for holding investments in the fund to reduce its downside risk and ensure that the returns become more predictable.
- Who manages the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan?The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan is managed by Priyanka Khandelwal (Since Jun 25, 2018) and Dharmesh Kakkad (Since May 02, 2020).
Date Sources: Mutual Funds, ETFs, and NPS data are sourced from Value Research. All times stamps are reflecting IST (Indian Standard Time). By using this site, you agree to the Terms of Service and Privacy Policy.
